Belgian Pediatric Drug Network BPDN Medicines for Children

Power Point presentation of BPDN

the European Regulation on Medicine for Pediatric Use has been adopted by the European Parliament on 7th September 2005. l. Text of modified proposal COM(2005) 577 final of 10 November 2005
Final agrement Eur Parl May 2006

In all actions concerning children, the best interests of the child shall be a primary consideration
Convention on the Rights of the Child art 3

BELGIAN PEDIATRIC DRUG NETWORK

BELGIAN PEDIATRIC CLINICAL TRIAL NETWORK
B.P.D.N.
pediatricdrug.be

MEMBER SPECIALITY OF THE BELGIAN SOCIETY OF PEDIATRICS BVK / SBP

update June2008

Belgian pediatric drug network - Belgian Pediatric Clinical Trial Network

Date and place of constitution: 20 January 2005, Academy of Medicine, Brussels
Founding committee:
Etienne SOKAL , president
Myriam VANWINCKEL , secretary
Karel ALLEGAERT
Daniel BRASSEUR
Jean Paul LANGHENDRIES
José RAMET
Johan VANDEWALLE
Bart VANOVERMEIRE

Aims
Articles
Usefull documents and links
Websites of interest
Current Trials
Conferences

AIMS

To place child health, rights and interest as the primary consideration (Convention on the Rights of the Child )
Enforce good clinical practice in belgian pediatic research and belgian clinical trials of new drugs
Propose a network of investigators for clinical trials of existing medicine products for children
- Establish a network of belgian pediatric units active in clinical research and pediatric clinical trials.
- Collaborate with other european networks in the field of clinical research and pediatric clinical trials.
Facilitate exchange of information and promote education on pediatric clinical research and pediatric clinical trials.
Offer a platform to perform clinical trials in pediatrics in Belgium: protocol proposal, discussion, and organisation
Offer ethical consideration and advisory board in the field of pediatric research and pediatric clinical trials
Discuss needs with third parties, in the Best Interest of the Child.
- Health authorities
- Patient's organisation
- Pharmaceutical industry
- Ethical committees
Attract attention on the problems related to drug use and clinical tirals in children:
- Need for children to have access to innovative and old drugs
- Unlicensed products for children
- Off label use
- Lack of pediatric studies
Extent activities in the field of non pharmaceutical collaborative clinical research